Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study

by Maud Rothärmel, Cherifa Benosman, Wissam El-Hage, Wissam El-Hage, Caroline Berjamin, Diane Ribayrol, Olivier Guillin, Olivier Guillin, Olivier Guillin, Raphaël Gaillard, Lucie Berkovitch, Lucie Berkovitch, Virginie Moulier, Virginie Moulier
Published 2022-07-01